Study of Nutritional Supplement Shakes in People About to Receive Their Debulking Surgery for Ovarian Cancer

Preoperative Nutrition Intervention for Patients Undergoing Primary Surgical Debulking of Ovarian Cancer: A Feasibility Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03956095

Enrollment

Registered

2019-05-20

Start date

2019-05-16

Completion date

2025-12-19

Last updated

2025-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Debulking Surgery for Ovarian Cancer

Keywords

Nutritional Supplement Shakes, 19-108

Brief summary

The purpose of this study is to find out if it is possible to establish a nutritional support program for people who are scheduled to receive primary debulking surgery. Design: This will be a prospective observational study to assess the feasibility of implementing a preoperative nutrition supplementation program.

Interventions

DIETARY_SUPPLEMENTEnsure Surgery Immunonutrition Shake supplements

Three Ensure Surgery Immunonutrition Shake supplements per day for seven days prior to their scheduled procedure.

OTHERDaily Food Intake form

On the day of surgery, the patient will return her Daily Supplement/Food Intake Forms and complete the Day of Surgery Intake Form can also be completed the day before surgery and the Daily Supplement/Food Intake Forms can be returned at the patient's postoperative appointment.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age ≥ 18 * Scheduled to undergo primary surgical debulking of ovarian, fallopian tube and primary peritoneal cancer * Have a sufficient preoperative window during which the intervention can occur, with the last day of supplementation at least one and no more than two days prior to surgery; scheduling of the procedure should not be delayed due to participation in this investigation

Exclusion criteria

* Have received neoadjuvant chemotherapy * Debulking surgery scheduled less than 8 days from initial visit * Are scheduled for a minimally invasive procedure * Unable to tolerate oral intake or have gastrointestinal issues that would prevent or prohibit oral supplement consumption * Have diabetes mellitus * Have allergies to the Ensure Surgery Immunonutrition Shake supplement * Have galactosemia

Design outcomes

Primary

Measure	Time frame
rate of patient participation	30 days after surgery

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026